The Study of Typical Conditions to Remove Co from Water by Adsorption by Using Activated Carbon

The effective removal of heavy metal ions from water is among the most important issues for many industrialized countries. The present work has been carried out to study the adsorption of cobalt [II] ion using activated carbon. The removal of cobalt ions was investigated in batch conditions. The influence of initial cobalt ion concentration, pH, adsorbent dose, adsorbent practical size; contact time and shaking rate were studied at room temperature. The analysis of residual Co [II] ions was determined using Atomic Absorption Spectrophotometer GBC 933 plus. The results showed that the percentage adsorption of activated carbon increases with time and that maximum adsorption was obtained within the first 60 minutes of the process, and 300 rpm shaking rate. The experiments showed that the maximum % adsorption of 100% was obtained at adsorbent dose=0.4 gm, pH=13, particle size= (0-75) μm and 10 mg/L of initial concentration of cobalt. These results indicate that activated carbon has potential for removing cobalt ions from water

Molecular Identification of Prevalent Streptococcus Pyogenes Serogroup Associated with Respiratory Tract Infections in Children

The current study intends to characterize the respiratory tract infections that have an association with gram positive bacterial pathogens, emm typing, the pattern of antibacterial resistance in isolated pathogens, phenotyping of virulence factor and molecular detection of Macrolide resistance gene. Various samples from patients with respiratory tract infections were collected and identification and antimicrobial susceptibility of clinical isolates was performed as per standard laboratory procedure.  Macrolides (Eruthromycin, Clindamycin)-resistant isolates were again subjected to MIC method. Macrolide-inducible resistance to clindamycin (D test) was conducted upon Erythromycin and Clindamycin discs. Multiplex PCR was used to detect the resistance genes in all the three types of macrolide resistance strains. Serum Opacity Factor (SOF) was detected for all the isolates of GAS. Every isolate was checked to produce biofilm through micro titre plate method. Bacterial growth got registered in 156 (36.28%) samples. The most common isolate from URI samples was GAS i.e., 64 (14.9%), only to be followed by GGS 38(8.8%), GCS 29 (6.7%) and Staphylococcus aureus 18 (4.2%). Among GAS, only one isolate was recorded from blood, whereas 8.50% from sputum and the rest. All 71 GAS isolates were found to exhibit sensitivity towards Penicillin and Ceftriazone. GAS exhibited 55% Mtype of resistance whereas 40% were resistant to cMLS and 5% to iMLS. GCS showcased an equal number of cMLS and M type too. GGS portrayed 54.54% resistance to cMLS followed by 36.36% to Mtype and 9.09% to iMLS. The current study found iMLS type with least resistance. The current study identified that Streptococcus pyogenes is the most common bacteria that cause and recur the infection. The prevalence of resistance tends to change geographically and periodically. For this purpose and to achieve a sound public health outcome, periodical screening of antibiotic-resistance pattern becomes inevitable

Levels of Lead and Chromium Ions in Different Brands of Lipstick Sold at Local Markets in Iraq

Lead and Chromium ion samples of five commercial samplesof each of twenty brands of lipstick sold at locally markets in Iraq weredetermined by atomic absorption spectrophotometer. Samples ofdigested Lipstick were used, acid digestion method using acids HCl:HNO3 in ratio 1:3 were used before analysis. Average for analyzedsamples were Pb, 0.10-4.85 ppm; Cr, 0.18-5.2 ppm. Samples No.9 andNo.4 showed the least concentrations of Pb and Cr respectively. Thesevalues are not expected to be toxic to humans. However, exposure overlong periods might cause accumulation of the elements in the body andeven at low concentration; some metals could initiate allergic reactions

Phenolic Profile of Herbal Infusion and Polyphenol-Rich Extract from Leaves of the Medicinal Plant Antirhea borbonica: Toxicity Assay Determination in Zebrafish Embryos and Larvae

International audienceAntirhea borbonica (A. borbonica) is an endemic plant from the Mascarene archipelago in the Indian Ocean commonly used in traditional medicine for its health benefits. This study aims (1) at exploring polyphenols profiles from two types of extracts-aqueous (herbal infusion) and acetonic (polyphenol rich) extracts from A. borbonica leaves-and (2) at evaluating their potential toxicity in vivo for the first time. We first demonstrated that, whatever type of extraction is used, both extracts displayed significant antioxidant properties and acid phenolic and flavonoid contents. By using selective liquid chromatography-tandem mass spectrometry, we performed polyphenol identification and quantification. Among the 19 identified polyphenols, we reported that the main ones were caffeic acid derivatives and quercetin-3-O-rutinoside. Then, we performed a Fish Embryo Acute Toxicity test to assess the toxicity of both extracts following the Organisation for Economic Cooperation and Development (OECD) guidelines. In both zebrafish embryos and larvae, the polyphenols-rich extract obtained by acetonic extraction followed by evaporation and resuspension in water exhibits a higher toxic effect with a median lethal concentration (LC 50 : 5.6 g/L) compared to the aqueous extract (LC 50 : 20.3 g/L). Our data also reveal that at non-lethal concentrations of 2.3 and 7.2 g/L for the polyphenol-rich extract and herbal infusion, respectively, morphological malformations such as spinal curvature, pericardial edema, and developmental delay may occur. In conclusion, our study strongly suggests that the evaluation of the toxicity of medicinal plants should be systematically carried out and considered when studying therapeutic effects on living organisms

The Pathophysiology of Long COVID throughout the Renin-Angiotensin System

COVID-19 has expanded across the world since its discovery in Wuhan (China) and has had a significant impact on people’s lives and health. Long COVID is a term coined by the World Health Organization (WHO) to describe a variety of persistent symptoms after acute SARS-CoV-2 infection. Long COVID has been demonstrated to affect various SARS-CoV-2-infected persons, independently of the acute disease severity. The symptoms of long COVID, like acute COVID-19, consist in the set of damage to various organs and systems such as the respiratory, cardiovascular, neurological, endocrine, urinary, and immune systems. Fatigue, dyspnea, cardiac abnormalities, cognitive and attention impairments, sleep disturbances, post-traumatic stress disorder, muscle pain, concentration problems, and headache were all reported as symptoms of long COVID. At the molecular level, the renin-angiotensin system (RAS) is heavily involved in the pathogenesis of this illness, much as it is in the acute phase of the viral infection. In this review, we summarize the impact of long COVID on several organs and tissues, with a special focus on the significance of the RAS in the disease pathogenesis. Long COVID risk factors and potential therapy approaches are also explored

The Pathophysiology of Long COVID throughout the Renin-Angiotensin System

COVID-19 has expanded across the world since its discovery in Wuhan (China) and has had a significant impact on people’s lives and health. Long COVID is a term coined by the World Health Organization (WHO) to describe a variety of persistent symptoms after acute SARS-CoV-2 infection. Long COVID has been demonstrated to affect various SARS-CoV-2-infected persons, independently of the acute disease severity. The symptoms of long COVID, like acute COVID-19, consist in the set of damage to various organs and systems such as the respiratory, cardiovascular, neurological, endocrine, urinary, and immune systems. Fatigue, dyspnea, cardiac abnormalities, cognitive and attention impairments, sleep disturbances, post-traumatic stress disorder, muscle pain, concentration problems, and headache were all reported as symptoms of long COVID. At the molecular level, the renin-angiotensin system (RAS) is heavily involved in the pathogenesis of this illness, much as it is in the acute phase of the viral infection. In this review, we summarize the impact of long COVID on several organs and tissues, with a special focus on the significance of the RAS in the disease pathogenesis. Long COVID risk factors and potential therapy approaches are also explored

The Renin-Angiotensin System: A Key Role in SARS-CoV-2-Induced COVID-19

International audienceThe novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the causative agent of coronavirus disease 2019 (COVID-19), was first identified in Eastern Asia (Wuhan, China) in December 2019. The virus then spread to Europe and across all continents where it has led to higher mortality and morbidity, and was declared as a pandemic by the World Health Organization (WHO) in March 2020. Recently, different vaccines have been produced and seem to be more or less effective in protecting from COVID-19. The renin–angiotensin system (RAS), an essential enzymatic cascade involved in maintaining blood pressure and electrolyte balance, is involved in the pathogenicity of COVID-19, since the angiotensin-converting enzyme II (ACE2) acts as the cellular receptor for SARS-CoV-2 in many human tissues and organs. In fact, the viral entrance promotes a downregulation of ACE2 followed by RAS balance dysregulation and an overactivation of the angiotensin II (Ang II)–angiotensin II type I receptor (AT1R) axis, which is characterized by a strong vasoconstriction and the induction of the profibrotic, proapoptotic and proinflammatory signalizations in the lungs and other organs. This mechanism features a massive cytokine storm, hypercoagulation, an acute respiratory distress syndrome (ARDS) and subsequent multiple organ damage. While all individuals are vulnerable to SARS-CoV-2, the disease outcome and severity differ among people and countries and depend on a dual interaction between the virus and the affected host. Many studies have already pointed out the importance of host genetic polymorphisms (especially in the RAS) as well as other related factors such age, gender, lifestyle and habits and underlying pathologies or comorbidities (diabetes and cardiovascular diseases) that could render individuals at higher risk of infection and pathogenicity. In this review, we explore the correlation between all these risk factors as well as how and why they could account for severe post-COVID-19 complications

Angiotensin II Type I Receptor (AT1R): The Gate towards COVID-19-Associated Diseases

International audienceThe binding of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike glycoprotein to its cellular receptor, the angiotensin-converting enzyme 2 (ACE2), causes its downregulation, which subsequently leads to the dysregulation of the renin–angiotensin system (RAS) in favor of the ACE–angiotensin II (Ang II)–angiotensin II type I receptor (AT1R) axis. AT1R has a major role in RAS by being involved in several physiological events including blood pressure control and electrolyte balance. Following SARS-CoV-2 infection, pathogenic episodes generated by the vasoconstriction, proinflammatory, profibrotic, and prooxidative consequences of the Ang II–AT1R axis activation are accompanied by a hyperinflammatory state (cytokine storm) and an acute respiratory distress syndrome (ARDS). AT1R, a member of the G protein-coupled receptor (GPCR) family, modulates Ang II deleterious effects through the activation of multiple downstream signaling pathways, among which are MAP kinases (ERK 1/2, JNK, p38MAPK), receptor tyrosine kinases (PDGF, EGFR, insulin receptor), and nonreceptor tyrosine kinases (Src, JAK/STAT, focal adhesion kinase (FAK)), and nicotinamide adenine dinucleotide phosphate (NADPH) oxidase. COVID-19 is well known for generating respiratory symptoms, but because ACE2 is expressed in various body tissues, several extrapulmonary pathologies are also manifested, including neurologic disorders, vasculature and myocardial complications, kidney injury, gastrointestinal symptoms, hepatic injury, hyperglycemia, and dermatologic complications. Therefore, the development of drugs based on RAS blockers, such as angiotensin II receptor blockers (ARBs), that inhibit the damaging axis of the RAS cascade may become one of the most promising approaches for the treatment of COVID-19 in the near future. We herein review the general features of AT1R, with a special focus on the receptor-mediated activation of the different downstream signaling pathways leading to specific cellular responses. In addition, we provide the latest insights into the roles of AT1R in COVID-19 outcomes in different systems of the human body, as well as the role of ARBs as tentative pharmacological agents to treat COVID-19